Author's posts
Reyvow, Migraine Drug That Treats Pain In Hours, Now Hits The Shelves
The drug is also being marketed as the first oral medication of its class to treat acute migraines and bothersome symptoms in adults with or without aura.
FDA Approve First And Only IV Treatment For Migraine Prevention
Overall, in the randomized double blind studies, patients’ mean migraine frequency changed from the baseline, of around 8.6 migraines per month, to 50 to 75 percent reduction in migraines over the course of several months.
New Player In The Fight Against Resistant Fungal Infections In Phase 3 Trial
Rezofungin hopes to fight increasingly deadly hospital-acquired fungal infections.
A Unique Nasal Spray Design Aims To Give Relief To Sinus Sufferers
When it comes to treatment for chronic rhinosinusitis, it’s not the drug that’s the problem, but rather finding a way to deliver it in hard to reach cavities of our sinuses.
First Time Ever, Artificial Intelligence Develops Drug Candidate
In the case of developing drugs, while DSP-1181 may have been the first, scientists are convinced it is far from the last.
Army Inches Closer To Develop Zika And Dengue Virus Vaccine
Mosquito-carried diseases such as the Zika virus and Dengue still continue to thrive in warm temperate parts of the world, but new US army research suggests we are on the cusp of figuring out a vaccine that could potentially work to fight both these in…
First Peanut Allergy Drug Gets FDA Thumbs Up
Palforzia is now approved for use in individuals aged 4 through 17 who have a confirmed diagnosis of peanut allergy.
FDA Approves First Drug For Treatment Of Thyroid Eye Disease
The drug is administered via intravenous therapy (IV), with eight infusions over a six month period. Each infusion can take between an hour to an hour and a half.
HPV-Cancer Targeting Immunotherapy Enters Phase 1 Clinical Trial After Showing Success In Animals
The paper highlights the candidate’s ability to target and shrink HPV motivated tumors in both animal studies and human blood samples.
Who’s Really At Risk For Poor Heart Health Due To Work Burnout?
The study was mostly focused on vital exhaustion, which is a combination of fatigue, irritability, and demoralization. This is far more than the average sleepless night or stressful deadline.
